NASDAQ: PBYI
Puma Biotechnology Inc Stock Ownership - Who owns Puma Biotechnology?

Insider buying vs selling

Have Puma Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alessandra CesanoDirector2025-07-1827,000$3.37
$90.91kSell
Alan H. AuerbachPresident and CEO2025-07-0921,580$3.54
$76.29kSell
Maximo F. NouguesChief Financial Officer2025-07-093,935$3.54
$13.91kSell
Douglas M. HuntOfficer2025-07-093,443$3.54
$12.17kSell
Alan H. AuerbachPresident and CEO2025-07-0825,592$3.53
$90.42kSell
Maximo F. NouguesChief Financial Officer2025-07-085,587$3.53
$19.74kSell
Douglas M. HuntOfficer2025-07-084,374$3.53
$15.45kSell
Troy Edward WilsonDirector2025-06-1310,800$3.40
$36.72kSell
Alessandra CesanoDirector2025-06-1312,150$3.40
$41.31kSell
Allison DorvalDirector2025-06-1311,610$3.40
$39.47kSell

1 of 2

PBYI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBYI insiders and whales buy or sell their stock.

PBYI Shareholders

What type of owners hold Puma Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC17.89%8,879,139$44.44MInsider
Alan H. Auerbach14.47%7,180,901$35.94MInsider
Acorn Capital Advisors LLC8.32%4,131,299$20.68MInstitution
Blackrock Inc7.73%3,835,715$19.20MInstitution
Vanguard Group Inc7.47%3,706,452$18.55MInstitution
Adage Capital Partners LP6.45%3,200,000$16.02MInsider
Acadian Asset Management LLC4.05%2,008,146$10.05MInstitution
Renaissance Technologies LLC3.78%1,874,713$9.38MInstitution
American Century Companies Inc2.70%1,342,275$6.72MInstitution
Dimensional Fund Advisors LP2.32%1,150,040$5.76MInstitution

1 of 3

PBYI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBYI60.14%39.86%Net SellingNet Selling
HUMA35.95%21.86%Net Selling
OABI44.82%26.40%Net Buying
IMMP0.11%0.00%
LXEO78.27%13.19%Net Buying

Puma Biotechnology Stock Ownership FAQ

Who owns Puma Biotechnology?

Puma Biotechnology (NASDAQ: PBYI) is owned by 66.04% institutional shareholders, 43.76% Puma Biotechnology insiders, and 0.00% retail investors. Adage Capital Partners GP LLC is the largest individual Puma Biotechnology shareholder, owning 8.88M shares representing 17.89% of the company. Adage Capital Partners GP LLC's Puma Biotechnology shares are currently valued at $45.19M.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.